Global Immuno-oncology Therapy Market Insights, Forecast to 2025

payment-methods
Secure Payment Methods

The Immuno-oncology Therapy Market report covers a number of parameters, such as standing of top market players, as well as the forecast of the next 5 years.

The report talks about past standings as well as upcoming predictions of the market. The report clearly demonstrates the information in terms of graphs and tables to easily identify the trends in the industry.

Below is the majority of content covered in this report

  • Immuno-oncology Therapy Product details, including pictures and technical specifications
  • Immuno-oncology Therapy manufacturers, distributors and channels
  • Major players present in the Immuno-oncology Therapy
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

The report covers the information pertaining to following geographies

  • United States
  • Canada
  • Mexico
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Brazil
  • Rest of Central & South America
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa

Additionally, the market is segmented by the following sectors

  • Monoclonal Antibodies
  • Immune Checkpoint Inhibitors
  • Immune System Modulators
  • Cancer Vaccines
  • Others

Please contact us if you are looking for any other possible breakdown across the products.

Not only this, figures covering the end user applications are also provided according to the following classification

  • Hospitals
  • Ambulatory Surgical Center
  • Others

In summary, the report serves to study and analyse the Immuno-oncology Therapy size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Immuno-oncology Therapy, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 1 Study Coverage
    • 1.1 Immuno-oncology Therapy Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type
      • 1.4.2 Monoclonal Antibodies
      • 1.4.3 Immune Checkpoint Inhibitors
      • 1.4.4 Immune System Modulators
      • 1.4.5 Cancer Vaccines
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Immuno-oncology Therapy Market Size Growth Rate by Application
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Center
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered
  • 2 Executive Summary
    • 2.1 Global Immuno-oncology Therapy Market Size
      • 2.1.1 Global Immuno-oncology Therapy Revenue 2016-2025
      • 2.1.2 Global Immuno-oncology Therapy Sales 2016-2025
    • 2.2 Immuno-oncology Therapy Growth Rate by Regions
      • 2.2.1 Global Immuno-oncology Therapy Sales by Regions
      • 2.2.2 Global Immuno-oncology Therapy Revenue by Regions
  • 3 Breakdown Data by Manufacturers
    • 3.1 Immuno-oncology Therapy Sales by Manufacturers
      • 3.1.1 Immuno-oncology Therapy Sales by Manufacturers
      • 3.1.2 Immuno-oncology Therapy Sales Market Share by Manufacturers
      • 3.1.3 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Immuno-oncology Therapy Revenue by Manufacturers
      • 3.2.1 Immuno-oncology Therapy Revenue by Manufacturers (2016-2018)
      • 3.2.2 Immuno-oncology Therapy Revenue Share by Manufacturers (2016-2018)
    • 3.3 Immuno-oncology Therapy Price by Manufacturers
    • 3.4 Immuno-oncology Therapy Manufacturing Base Distribution, Product Types
      • 3.4.1 Immuno-oncology Therapy Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Immuno-oncology Therapy Product Category
      • 3.4.3 Date of International Manufacturers Enter into Immuno-oncology Therapy Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 4 Breakdown Data by Type
    • 4.1 Global Immuno-oncology Therapy Sales by Type
    • 4.2 Global Immuno-oncology Therapy Revenue by Type
    • 4.3 Immuno-oncology Therapy Price by Type
  • 5 Breakdown Data by Application
    • 5.1 Overview
    • 5.2 Global Immuno-oncology Therapy Breakdown Data by Application
  • 6 North America
    • 6.1 North America Immuno-oncology Therapy by Countries
      • 6.1.1 North America Immuno-oncology Therapy Sales by Countries
      • 6.1.2 North America Immuno-oncology Therapy Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Immuno-oncology Therapy by Type
    • 6.3 North America Immuno-oncology Therapy by Application
    • 6.4 North America Immuno-oncology Therapy by Company
  • 7 Europe
    • 7.1 Europe Immuno-oncology Therapy by Countries
      • 7.1.1 Europe Immuno-oncology Therapy Sales by Countries
      • 7.1.2 Europe Immuno-oncology Therapy Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Immuno-oncology Therapy by Type
    • 7.3 Europe Immuno-oncology Therapy by Application
    • 7.4 Europe Immuno-oncology Therapy by Company
  • 8 Asia Pacific
    • 8.1 Asia Pacific Immuno-oncology Therapy by Countries
      • 8.1.1 Asia Pacific Immuno-oncology Therapy Sales by Countries
      • 8.1.2 Asia Pacific Immuno-oncology Therapy Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Immuno-oncology Therapy by Type
    • 8.3 Asia Pacific Immuno-oncology Therapy by Application
    • 8.4 Asia Pacific Immuno-oncology Therapy by Company
  • 9 Central & South America
    • 9.1 Central & South America Immuno-oncology Therapy by Countries
      • 9.1.1 Central & South America Immuno-oncology Therapy Sales by Countries
      • 9.1.2 Central & South America Immuno-oncology Therapy Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Immuno-oncology Therapy by Type
    • 9.3 Central & South America Immuno-oncology Therapy by Application
    • 9.4 Central & South America Immuno-oncology Therapy by Company
  • 10 Middle East and Africa
    • 10.1 Middle East and Africa Immuno-oncology Therapy by Countries
      • 10.1.1 Middle East and Africa Immuno-oncology Therapy Sales by Countries
      • 10.1.2 Middle East and Africa Immuno-oncology Therapy Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Immuno-oncology Therapy by Type
    • 10.3 Middle East and Africa Immuno-oncology Therapy by Application
    • 10.4 Middle East and Africa Immuno-oncology Therapy by Company
  • 11 Company Profiles
    • 11.1 Amgen
      • 11.1.1 Amgen Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.1.4 Immuno-oncology Therapy Product Description
      • 11.1.5 Recent Development
    • 11.2 AstraZeneca
      • 11.2.1 AstraZeneca Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.2.4 Immuno-oncology Therapy Product Description
      • 11.2.5 Recent Development
    • 11.3 Bristol-Myers Squibb
      • 11.3.1 Bristol-Myers Squibb Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.3.4 Immuno-oncology Therapy Product Description
      • 11.3.5 Recent Development
    • 11.4 Eli-Lilly
      • 11.4.1 Eli-Lilly Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.4.4 Immuno-oncology Therapy Product Description
      • 11.4.5 Recent Development
    • 11.5 Roche
      • 11.5.1 Roche Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.5.4 Immuno-oncology Therapy Product Description
      • 11.5.5 Recent Development
    • 11.6 GlaxoSmithKline
      • 11.6.1 GlaxoSmithKline Company Details
      • 11.6.2 Company Description
      • 11.6.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.6.4 Immuno-oncology Therapy Product Description
      • 11.6.5 Recent Development
    • 11.7 Janssen Biotech
      • 11.7.1 Janssen Biotech Company Details
      • 11.7.2 Company Description
      • 11.7.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.7.4 Immuno-oncology Therapy Product Description
      • 11.7.5 Recent Development
    • 11.8 Merck
      • 11.8.1 Merck Company Details
      • 11.8.2 Company Description
      • 11.8.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.8.4 Immuno-oncology Therapy Product Description
      • 11.8.5 Recent Development
    • 11.9 Novartis
      • 11.9.1 Novartis Company Details
      • 11.9.2 Company Description
      • 11.9.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.9.4 Immuno-oncology Therapy Product Description
      • 11.9.5 Recent Development
    • 11.10 Pfizer
      • 11.10.1 Pfizer Company Details
      • 11.10.2 Company Description
      • 11.10.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
      • 11.10.4 Immuno-oncology Therapy Product Description
      • 11.10.5 Recent Development
    • 11.11 Sanofi
    • 11.12 Spectrum Pharmaceuticals
    • 11.13 Takeda
  • 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators
  • 13 Value Chain and Sales Channels Analysis
    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key Immuno-oncology Therapy Raw Material
      • 13.1.2 Immuno-oncology Therapy Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors
  • 14 Research Findings and Conclusion
  • 15 Appendix
    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
        • 15.1.1.1 Research Programs/Design
        • 15.1.1.2 Market Size Estimation
        • 15.1.1.3 Market Breakdown and Data Triangulation
      • 15.1.2 Data Source
        • 15.1.2.1 Secondary Sources
        • 15.1.2.2 Primary Sources
    • 15.2 Author Details
    • 15.3 Disclaimer

Request a FREE Sample


PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers

Request a FREE Sample